Because the S protein of SARS-CoV-2 plays a vital role in receptor binding and membrane fusion, vaccines targeting the S protein are suggested to be capable of inducing antibodies that can neutralize virus infection by blocking virus binding and fusion (181). The gene discussed is PROS1; the disease is viral infectious disease.